GL1X · GenesisL1 explorer

MolNFT v1 · #179101 · protein

Crystal structure of the SARS-cov-2 spike receptor-binding domain (rbd) with nanobody NB20

7JVB · Spike protein S1: “Crystal structure of the SARS-cov-2 spike receptor-binding domain (rbd) with nanobody NB20”. X-ray diffraction, 6 pockets (best druggability 0.69). MolNFT v1 #179101 on GenesisL1: 3D structure, binding sites and…

PDB
7JVB
Type
protein
Length
621 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; Nanobody NB20
UniProt
P0DTC2
Pockets
6 · best druggability 0.69

Structure

x-ray diffraction · 3 distinct chains · 10% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19413% helix, 26% strandP0DTC2
C, DNanobody NB20protein1170% helix, 50% strand—
BSpike protein S1protein19313% helix, 26% strandP0DTC2

Ligands and binding sites

  • CAC · Cacodylate ion · additive · 4 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.690.9219empty
2920.660.9018empty
3550.600.9221empty
4530.560.9018empty
51130.400.7518empty

Interfaces

2 interfaces between chains.

  • B–D · 762 Ų buried · 10 hydrogen bonds · protein-protein
  • A–C · 755 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 7JVB · Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.